Dr. Prosenjit Saha Senior Scientific Officer(Asst. Dir Gr.)
Department: Cancer Research
Education
Ph.D. 2005, in life Science and Biotechnology, Jadavpur University, Kolkata, India
M.Sc. 1998 (Botany), University of Kalyani, India
B. Sc. Botany (Hons) 1996, University of Kalyani, India
Tel. 91-33-2476-5101 (ext-316),
Email: prosenjit_cnci@yahoo.co.in
Position
| Position/Post Held | Institute/Organization/Location | Duration |
| Senior Scientific Officer -I (Assistant Director Grade) | Chittaranjan National Cancer Institute, Kolkata, India | 2022 - till Now |
| Head of the Department | Chittaranjan National Cancer Institute, Kolkata, India | 2017 - till Now |
| Senior Scientific Officer -I | Chittaranjan National Cancer Institute, Kolkata, India | 2015 - 2022 |
| Senior Scientific Officer-II | Chittaranjan National Cancer Institute, Kolkata, India | 2009 - 2015 |
| Post Doc Fellow | West Virginia University, Morgantown, West Virginia, USA | 2005-2009 |
Research Interest
My research is centered on the identification and
characterization of novel bioactive natural compounds derived from dietary
sources, including food, beverages, spices, and medicinal plants, with
potential applications in cancer therapy. The primary objective is to evaluate
their cytoprotective efficacy in mitigating chemotherapy-induced toxicity,
while simultaneously enhancing tumor cell sensitivity to conventional
anticancer agents. A key emphasis of our work is the investigation of molecular
mechanisms underlying the modulation of cancer stem cells (CSCs)
by these natural compounds. We aim to elucidate their role in disrupting
CSC-driven pathways associated with tumor initiation, progression, drug
resistance, and recurrence. In parallel, our research explores the
anti-angiogenic potential of these compounds, particularly in combination with
standard chemotherapeutic regimens, to inhibit tumor vascularization and
improve therapeutic outcomes. Through integrative in vitro and in vivo
approaches, we seek to identify synergistic interactions that enhance efficacy
while minimizing adverse effects.
Collectively, these studies are directed toward the
development of innovative, mechanism-based combinatorial strategies for cancer
prevention and treatment, with a focus on overcoming chemoresistance and
reducing tumor relapse.
Research Paper published
2026 Evaluation of the Diagnostic
Accuracy of Cervical Cell Morphologies from Android Device-Captured
Cytopathological Microscopic Images through Artificial Intelligence in Mainly
Rural or Resource-Constraint Areas of IndiaA. Ray, A. Karmakar, M.Maiti, S. Banerjee,
S. Dasgupta, S. Dey, U. Faruk, P. Das, P.
Saha, Asian Pac J Cancer Prev,
, 27 (2), 601-612
2025
Attenuation of paclitaxel-induced toxicities by
polyphenolic natural compound rutin through inhibition of apoptosis and
activation of NRF2/ARE signaling pathways, S Biswas, M Mondal, S Pakhira, R
Ghosh, P Samanta, J Basu, A Bhowmik, Hajra S., Saha
P. Food and Chemical
Toxicology, 200, 115408
2025
A short synthesis of carbohydrate derived N-benzyl
aminocyclopentitols through N–O bond cleavage of the corresponding
isoxazolidine derivatives: Evaluation of their anticancerproperties using in
vitro and in silico studies, T Halder, R Ghosh, A Sahoo, SS Swain, R Hore, S
Ghosh, Saha P., Maity J., Carbohydrate
Research 552, 109465
2025 Natural flavonoid
Orientin restricts 5-Fluorouracil induced cancer stem cells mediated
angiogenesis by regulating HIF1α and VEGFA in colorectal cancer, Ghosh R,
Bhowmik A., Biswas S., Samanta P., Sarkar R., Pakhira S., Mondal M., Hajra S., Saha P, Molecular
Medicine, 5;31(1):85. doi:
10.1186/s10020-024-01032-1.
2024 Crude extract of
Ruellia tuberosa L. flower induces intracellular ROS, promotes DNA damage and
apoptosis in Triple Negative Breast Cancer Cells: Guha S., Talukdar D., Mandal
G, Mukherjee R., Ghosh S., Naskar R., Saha P., Murmu N., Das G.,
Journal of Ethnopharmacology, Volume 332, 5 October 2024, 118389.
2024 Targeting Cancer
Stem Cells by Natural Compounds in Combination with Conventional Chemotherapy:
An Ideal Strategy for Combating Cancer Recurrence, Ghosh R., Biswas S., Samanta
P., Sarkar R., Pakhira S., Mondal M, Bhowmik A, Hajra S, Saha P., Journal
of Current Oncological Trends 1 (1), 14-21.
2024 Exosome-sheathed
porous silica nanoparticle-mediated co-delivery of 3, 3′ diindolylmethane and
doxorubicin attenuates cancer stem cell-driven EMT in triple negative breast
cancer: Sarkar R., Biswas S., Ghosh R., Samanta P., Pakhira S., Mondal M.,
Dutta Gupta Y., Bhandary S., Saha
P., Bhowmik A, Hajra S., Journal of Nanobiotechnology 22 (1), 1-25.
2024 Current
Understanding on Impact of Kirsten Rat Sarcoma Viral Oncogene Mutation on
Colorectal Cancer: A Review, Pakhira P., Samanta P., Ghosh R., Mondal M.,
Biswas S., Sarkar R., Bhowmik A, Saha
P., Subhadip Hajra, Journal of Current Oncological Trends 1 (1), 8-13.
2024 Ribosome biogenesis and ribosomal proteins in
cancer stem cells: a new therapeutic prospect
Samanta P., Ghosh R., Pakhira S.,
Mondal M, Biswas S., Sarkar R., Bhowmik A., Saha P., Hajra S, Molecular Biology Reports. 51 (1), 1-17.
2023 Herapeutic
Effectiveness of Anticancer Agents Targeting Different Signaling Molecules
Involved in Asymmetric Division of Cancer Stem Cell:Samanta P, Bhowmik A, Biswas S, Sarkar R, Ghosh R, Pakhira S, Mondal M,
Sen S, Saha P, Hajra S.Stem Cell Rev Rep.https://doi.org/10.1007/s12015-023-10523-3.
2022
Targeting HIF-1α by Natural and Synthetic Compounds: A Promising
Approach for Anti- Cancer Therapeutics Development, R Ghosh, P Samanta, R
Sarkar, S Biswas, P Saha, S Hajra, A Bhowmik. Molecules 27 (16), 5192
2022 Evaluation of chemopreventive potential of
xanthone from Swertia chirata against DMBA/croton oil-induced chemical
carcinogenesis in Swiss mice,Barua
A., Choudhury P., Panda C., Saha P., Current Science,
February 2022122(4):429-438, DOI: 10.18520/cs/v122/i4/429-438
2022 Novel Xanthone from Swertia Chirata Exerts
Chemotherapeutic Potential Against Colon Carcinoma. Atish Barua, Pritha
Choudhury, Niraj Nag, Anirban Nath,
Sabyasachi Kundagrami, Amit Pal, Chinmay Kumar Panda and Prosenjit
Saha, Current Science, Jan 2022, VOL. 122, NO. 1, 10 DOI: 10.18520/cs/v122/i1/47-55.
2022 Deregulation of the
CD44-NANOG-MDR1 associated chemoresistance pathways of breast cancer stem cells
potentiate the anti-cancer effect of Kaempferol in synergism with Verapamil. Nandi
S.K., Roychowdhury
T.,
Chattopadhyay S., Basu S. , Chatterjee K.,
Choudhury P., Banerjee N., Saha P, Mukhopadhyay S., Mukhopadhyay A.,
Bhattacharya R., Toxicol Appl Pharmacol. 2022
Jan 18;115887. doi: 10.1016/j.taap.2022.115887.
2021 Downregulation of
Hyaluronic acid-CD44 signaling pathway in cervical cancer cell by natural
polyphenols Plumbagin, Pongapin and Karanjin., Roy R, Mandal S, Chakrabarti J, Saha P, Panda CK. Mol
Cell Biochem. 2021 Jun 3. doi: 10.1007/s11010-021-04195-1. Online ahead
of print. PMID: 34081254
2021 In silico validation of potent phytochemical orientin as inhibitor of
SARS-CoV-2 spike and host cell receptor GRP78 binding.
Bhowmik A, Biswas S, Hajra S, Saha P.Heliyon. 2021 Jan; 7(1):
e05923. doi: 10.1016/j.heliyon. 2021.e05923. Epub 2021 Jan 11.
PMID: 33458435
2021 Eugenol emerges as
an elixir by targeting β-catenin, the central Cancer Stem Cell regulator in
lung carcinogenesis: an in vivo and in vitrorationale, Choudhury
P., Atish Barua A., Roy
A., Pattanayak R., Bhattacharyya
M. and Saha P., FoodFunct. 2021 Feb 15;12(3):1063-1078.
doi: 10.1039/d0fo02105a.PMID: 33443517
2020 Chemotherapeutic
potential of novel xanthone sourced from Swertia
chirata against skin carcinogenesis. Barua
A., Choudhury P., Panda C.K., Saha P., Asian
Journal of Pharmaceutical and Clinical Research, 13(12):84-88, DOI: 10.22159/ajpcr. 2020.
v13i12.38942
2020
Anti-Metastatic
Potential of a Novel Xanthone Sourced by Swertia chirata Against In Vivo and In Vitro Breast Adenocarcinoma
Frameworks. Barua A, Choudhury P, Mandal S, Panda CK, Saha P. Asian
Pac J Cancer Prev. 2020 Oct 1;21(10):2865-2875. doi: 10.31557/ APJCP.
2020.21.10.2865. PMID: 33112542
2020
Therapeutic potential of xanthones from Swertia chirata in
breast cancer cells. Barua A., Choudhury P., Mandal S., Panda C.K., Saha
P.,Indian J Med Res. 2020 Sep;152(3):285-295. doi:
10.4103/ijmr.IJMR_1153_18.PMID: 33107489.
2020
Eugenol restricts Cancer Stem Cell population by degradation of
β-catenin via N-terminal Ser37
phosphorylation-an in vivo and in vitro experimental evaluation. Choudhury P.,
Barua A., Roy A., Pattanayak R., Bhattacharyya M., Saha P.,Chem Biol Interact. 2020 Jan 25; 316:108938. doi:
10.1016/j.cbi.2020.108938. Epub 2020 Jan 8.
2019 Pongapin and Karanjin, furanoflavanoids of Pongamia
pinnata, induce G2/M arrest and apoptosis in cervical cancer cells by
differential reactive oxygen species modulation, DNA damage, and nuclear factor
kappa-light-chain-enhancer of activated B cell signaling. Roy R., Pal D., Sur
S., Mandal S., Saha P., Panda C.K.,Phytother
Res. 2019 Mar 5, PMID:30834631
2019
Chemotherapeutic potential of novel
non-toxic nucleoside analogues on EAC ascitic tumour cells. Barua A, Choudhury P, Maity JK, Mandal
SB, Mandal S, Saha P. Free
Radic Res. 2019 Jan 9:1-11. PMID:30624093
2018 Indole-3-Carbinol
(I3C) enhances the sensitivity of murine breast adenocarcinoma cells to
doxorubicin (DOX) through inhibition of NF-κβ, blocking angiogenesis and
regulation of mitochondrial apoptotic pathway.Hajra
S., Patra A.R., Basu A., Saha P., Bhattacharya S.,Chem Biol Interact. 2018 May
15. PMID:29775573
2017
Tobacco‑induced Carcinogenesis
and Chemoprevention by Some Natural Products. Debolina
Pal, Subhayan Sur, Prosenjit Saha,
Chinmay Kumar Panda. Journal of
Radiation and Cancer Research, 8:35-43, 2017
2016 Tea polyphenols EGCG and TF restrict tongue and
liver carcinogenesis simultaneously induced by N-nitrosodiethylamine in mice.
Sur S., Pal D., Roy R., Barua A., Roy A., Saha P., Panda C.K.,Toxicol Appl Pharmacol. 2016 Jun
2015 Molecular
mechanism of regulation of villus cell Na-K-ATPase in the chronically inflamed
mammalian small intestine. Saha P,
Manoharan P, Arthur S, Sundaram S, Kekuda R, Sundaram U. Biochim Biophys Acta.
2015 Feb;1848(2):702-11. PMID: 25462166.
2012 Regulation of sodium-glutamine cotransport in
villus and crypt cells by glucocorticoids during chronic enteritis. Arthur S, Saha P, Sundaram S, Kekuda R, Sundaram
U. Inflamm
Bowel Dis. 2012 Apr. PMID:22508450
2012
Na-glutamine co-transporters B(0)AT1 in villus and Sn2 in crypts are
differentially altered in chronically inflamed rabbit intestine. Saha P, Arthur S, Kekuda R, Sundaram U.
Biochim
Biophys Acta. 2012; 1818(3):434-42PMID:22100603
2011 Reciprocal regulation of the primary sodium
absorptive pathways in rat intestinal
epithelial cells. Coon S, Kekuda R, Saha P, Sundaram U. Am
J Physiol Cell Physiol. 2011 Mar;300(3): C496505. PMID 21148403
2010 Highlighting the anti-carcinogenic potential
of an ayurvedic medicinal plant, Swertia Chirata. Saha P., Das S.,Asian Pac J Cancer Prev.
2010;11(6):1445-9. Review. PMID: 21338178.
2010 Glucocorticoids differentially regulate
Na-bile acid cotransport in normal and chronically inflamed rabbit ileal villus
cells. Coon S., Kekuda R., Saha P., Sundaram U.,Am J
PhysiolGastrointest Liver Physiol. 2010 May;298(5): G675-82. PMID:
20075140
2009 Mechanism of Inhibition of Iron Absorption in
the Chronically Inflamed Small IntestineOstrinsky Y. Saha P. Kekuda R. and Sundaram U. Gastroenterology, Vol.
136, Issue 5, Supplement 1, Page A-711
2008 Role of Sp1 and HNF1 transcription factors in
SGLT1 regulation during chronic
intestinal inflammation. Kekuda R., Saha
P., and Sundaram U. Am. J.
Physiol. 2008 Jun;294(6): G1354-61. PMID: 18339704
2008 Identification and characterization of rabbit
small intestinal villus cell brush-border membrane Na-glutamine co-transporter.
Talukder J., Kekuda R., Saha P.,
Arthur S. and Sundaram U.,Am.
J. Physiol. 2008 Jul;295(1): G7-G15. PMID:
18436625
2008 Constitutive
Nitric Oxide Differentially Regulates Na-H and Na-glucose co-Transport In
Intestinal Epithelial Cells. Coon S, Kekuda R., Saha P., Talukder J. and Sundaram U., Am. J. Physiol. 2008 Jun;294(6):
G1369-75.PMID: 18325982
2008 Mechanism of Leukotriene D4 inhibition of
Na-alanine co-transport in intestinal epithelial cells. Talukder J., Kekuda R.,
Saha P.and Sundaram U.,Am.
J. Physiol. 2008 Jul;295(1): G1-G6. PMID: 18436626.
2008 Functional characterization, localization
and molecular identification of rabbit intestinal N-amino acid
transporter. Talukder J., Kekuda R., Saha P., Prasad P.D., Ganapathy V. and
Sundaram U. Am. J. Physiol. 2008
Jun;294(6): G1301-10. PMID: 18388187.
2006
Differential alterations in metabolic pattern of the spliceosomalUsnRNAs during
pre-malignant lung lesions induced by benzo(a)pyrene: modulation by tea
polyphenols. Manna S., Banerjee S., Saha
P., Das S, Panda C.K., Mol Cell Biochem. 2006
Sep;289(1-2):149-57. PMID: 16718374.
2006
Amarogentin can reduce
hyperproliferation by downregulation of Cox-II and upregulation of apoptosis in
mouse skin carcinogenesis model, Saha P.,
Mandal S., Das A., Das S., in Cancer Letters, 2006 Dec
8;244(2):252-9. PMID: 1651706.
2005 Inhibition of growth, induction of apoptosis
and alteration of gene expression by tea polyphenols in the highly metastatic
human lung cancer cell line NCI-H460 Ganguly C, Saha P, Panda C.K., Das S.,Asian Pac J Cancer Prev. 2005
Jul-Sep; 6(3):326-31, PMID: 16235994.
2005 Black tea extract can modulate protein
expression of H-ras, c-Myc, p53, and Bcl-2 genes during pulmonary hyperplasia,
dysplasia, and carcinoma in situ. Saha
P., Banerjee S., Ganguly C., Manna S., Panda C.K., Das S.,J
Environ PatholToxicol Oncol. 2005;24(3):211-24. PMID: 16050805.
2005
Black tea polyphenols suppress
cell proliferation and induce apoptosis during benzo(a)pyrene-induced lung
carcinogenesis., Banerjee, S., Manna, S., Saha,
P., Panda C.K., Das, S.,European Journal of Cancer Prevention.
June 2005, 14(3):215-221.
2004 Evaluation of the anticarcinogenic activity
of Swertia chirataBuch.Ham, an Indian medicinal plant, on DMBA-induced
mouse skin carcinogenesis model. Saha P., Mandal S., Das A., Das P.C., Das S.,Phytother
Res. 2004 May;18(5):373-8. PMID: 15173996.
2004 The models for assessment of chemopreventive
agents: single organ models. Das S., Banerjee S., Saha P.,Asian Pac J Cancer Prev. 2004 Jan-Mar;5(1):15-23. Review. PMID:
15074999.
2003 Regulation of hazardous exposure by
protective exposure: modulation of phase II detoxification and lipid
peroxidation by Camellia sinensis and Swertia chirata. Saha P., Das S.,TeratogCarcinog Mutagen. 2003; Suppl
1:313-22. PMID: 12616622.
2003 Component of black tea can inhibit chemically
induced colon carcinogenesis through modulation of cyclooxygenase-2 activity”
Sengupta A., Ghosh S., Sanyal U., Saha
P., Das S.,Experimental Oncology, 2003;25: 170-175.
2002 Elimination of Deleterious Effects of Free
Radicals in Murine Skin Carcinogenesis by Black Tea Infusion, Theaflavins & Epigallocatechin
Gallate. Saha P., Das S.,Asian
Pac J Cancer Prev. 2002;3(3):225-230. PMID: 12718579.
Extramural Project
|
Title of the project |
Role/ Year |
Funding Agency |
|
Evaluation of potent anti-tumour
activities of some natural phenolic compounds |
Co-P 2014-2016 |
DST, WB |
|
Exosome mediated co-delivery of natural
flavonoid orientin and 5- Fluorouracil for targeting colorectal cancer stem
cells involved in angiogenic progression |
PI 2022-2025 |
SERB Core Research Grant
|
|
Inhibition of asymmetric division of
triple negative breast cancer stem cells by porous silicon nanoparticle
sheathed exosome mediated co-delivery of 3,3’-diindolylmethane and
doxorubicin” |
Co-PI 2024-2026 |
ICMR |
|
Development and Evaluation of Recombinant
anti-HER2 ScFv for Targeted Breast Cancer Therapy: Production,
Characterization, Therapeutic Efficacy Analysis through in vitro and in
vivo studies |
Co-PI 2025-2027 |
ICMR |
Present Lab members
|
Head of the Department |
Designation |
|
Dr. Prosenjit Saha, M.Sc., Ph.D |
Assistant
Director(Grade) |
|
Faculty |
|
|
Dr. Subhadip Hajra, M.Sc.Ph.D |
Senior
Scientific Officer Grade‐II |
|
Post-Doctoral
Fellow |
|
|
Dr. Jhinuk Basu- |
ICMR Project Research Scientist-II |
|
Research
Scholars |
|
|
Mr. Souradeep Biswas |
ICMR-SRF |
|
Ms. Rituparna Ghosh |
ICMR-SRF |
|
Ms. Priya Samanta |
CSIR-SRF |
|
Ms. Shampa Pakhira |
CSIR-SRF |
|
Ms. Mrinmoyee Mondal |
CNCI-SRF |
|
Ms. Madhurima Biswas |
(DBT-JRF) |
Opportunity
We invite applications from highly motivated doctoral and
postdoctoral candidates with a strong interest in phytochemicals and cancer
stem cell (CSC) research. Applicants should have an independent source of
funding and a demonstrated commitment to translational cancer research.
Candidates whose research interests align with our work on natural compounds,
cytoprotection, modulation of CSCs, and combinatorial therapeutic strategies
are particularly encouraged to apply.
Interested applicants are requested to send the following
documents:
- Curriculum
Vitae (including the names and contact details of three referees)
- Statement
of Purpose outlining research interests and career goals
Please email your application to: prosenjit_cnci@yahoo.co.in



